ARTICLE | Clinical News
Avastin bevacizumab: Phase III started
January 26, 2009 8:00 AM UTC
Last quarter, Genentech began the open-label Phase III ECOG 1305 trial to evaluate cisplatin plus docetaxel or fluorouracil with or without IV Avastin in 400 patients. Genentech markets Avastin in the...